Skip to main navigation Skip to search Skip to main content

A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO- 305) versus Ibrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314)

  • Si Lun Tam, Con (Primary Chief Investigator (PCI))
  • Renwick, William (Chief Investigator (CI))
  • Johnston, Anna M. (Chief Investigator (CI))
  • Hahn, Uwe H. (Chief Investigator (CI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

StatusNot started

Keywords

  • Clinical trial
  • Lymphoma
  • LOXO- 305

Clinical Trial Phase

  • Phase III (a & b)